AU Patent

AU2011212564A1 — Medicated module with lockable needle guard

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2012-08-16 · 14y expired

What this patent protects

A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device (7) containing a primary medicament accepts a medicated module (4) containing a single dose of a secondary medicament and where both medicaments are …

USPTO Abstract

A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device (7) containing a primary medicament accepts a medicated module (4) containing a single dose of a secondary medicament and where both medicaments are delivered through a single hollow needle (3). The medicated module (4) is configured so that it will first deliver both the primary and secondary medicaments and then, if needed, a dose(s) of additional primary medicament. The module (4) also contains a needle guard (22) that locks the first dose delivery, but can be manually overridden by a user to perform a second or subsequent injection of primary medicament.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011212564A1
Jurisdiction
AU
Classification
Expires
2012-08-16
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.